SCHEMBL31455002

SCHEMBL31455002

CC(C)(C)OC(=O)Nc1ccc(Nc2nc(-c3ccccc3)ccc2[N+](=O)[O-])cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.49
BRD4 O60885 2/20 0.45
BCL2 P10415 1/20 0.43
BECN1 Q14457 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MCL1 Q07820 1/20 0.43
PTK2B Q14289 1/20 0.43
GSK3B P49841 3/20 0.41
AURKA O14965 2/20 0.41
GSK3A P49840 2/20 0.41
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455077 0.89 ABCG2 (0.41) PRMT1BRD4ABCG2MEN1KMT2A
SCHEMBL31420343 0.88 PRMT1 (0.41) PRMT1BRD4BCL2BECN1ABCG2
SCHEMBL31455107 0.88 BRD9 (0.41) PRMT1BRD4BCL2BECN1MEN1
SCHEMBL17109515 0.87 BRD4 (0.49) BRD4ABCG2MEN1KMT2AMAPT
SCHEMBL31420320 0.87 BRD4 (0.49) BRD4ABCG2MEN1KMT2AMAPT
SCHEMBL31455106 0.87 SYK (0.40) PRMT1BCL2BECN1ABCG2MEN1
SCHEMBL31455545 0.87 ABCG2 (0.41) PRMT1BRD4BCL2BECN1ABCG2
SCHEMBL30826679 0.86 MAPT (0.41) PRMT1BRD4ABCG2MEN1KMT2A
SCHEMBL25385291 0.85 ABCG2 (0.41) ABCG2MEN1KMT2AMAPTCYP1A2
SCHEMBL30574901 0.85 ABCG2 (0.41) ABCG2MEN1KMT2AMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed